NCT04377152|Unknown
Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer
Expanded Access: 68Gallium-PSMA-11 for PET Imaging of Prostate Cancer
Loading search results
Expanded Access: 68Gallium-PSMA-11 for PET Imaging of Prostate Cancer
Sponsor study identifier
Secondary identifiers
OTHER · University of California, San Francisco
expanded_access
N/A
1 country
1
Study Start
Not reported
Date not reportedPrimary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThis expanded access protocol provides eligible participants with investigational 68Ga-PSMA-11 PET imaging to detect and localize prostate cancer for initial and subsequent treatment strategy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 1, 2020
Actual (reported)May 7, 2020
Actual (reported)PSMA-11 Ga 68 Injection is a positron emitting radiopharmaceutical containing radioactive 68Ga-labeled Glu-NH-CO-NH-Lys(Ahx)-HBED-CC (PSMA-11), which is used for diagnostic purposes in conjunction with Positron Emission Tomography (PET).
A PET scan is an imaging test that helps reveal how your tissues and organs are functioning using a radioactive drug (tracer) to show this activity
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University of California, San Francisco
San Francisco, California, 94143, United States
Thomas Hope, MD
University of California, San Francisco
First Submitted
May 1, 2020
First Posted
May 7, 2020
Last Updated
March 1, 2021
Record last verified: 2021-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
Contact the study team to confirm eligibility.